Natco Pharma Limited (NATCOPHARM) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Natco Pharma Limited stock ₹1,078, price ₹829, upside +30.1%, quality 59 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Natco Pharma Limited
NATCOPHARM · NSECheap (23% below fair value) and solid company, but price moving sideways: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range ₹511.63 – ₹1,577 · fair‑value band ₹704.99 – ₹1,617 · the ₹828.65 price screens below the ₹1,078 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether Natco Pharma is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
Show moreShow less
The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care.
It also provides orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services.
In addition, the company offers neurology, cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company provides agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops.
NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
Stock analysis
Natco Pharma Limited (NATCOPHARM) currently trades at ₹828.65, while our model-based Fair Value estimate is ₹1,078, implying the stock looks roughly 23% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹1,503 per share, and 18 of the 26 models we run sit above the ₹828.65 price.
Bear case: the Dividend Discount group reads lowest at ₹107.83, and 8 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹704.99 (bear) to ₹1,617 (bull), the price of ₹828.65 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 59/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Natco Pharma Limited reported revenue of ₹40.8B in FY2026 versus ₹19.5B in FY2022, a compound +20.3%/yr. Reported net income was ₹14.2B in FY2026, compounding +70.0%/yr from FY2022. FY2022 was a trough year, so the rate overstates the trend.
Key figures
Market cap ₹148B (≈ $1.6B) Small · P/E ratio 13.1 · P/S ratio 4.55 · EPS (TTM) ₹63.37 · Dividend yield 0.4% · Net margin 32.8% · Return on equity 16.9% · Return on assets (EBIT) 24.7% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 76 out of 100 (medium confidence).
What moves the price
The share trades about 31% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 30%, NATCOPHARM screens cheaper than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch NATCOPHARM, get fair value alerts →
Compare Natco Pharma Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Quality Score by industry
- Return on equity by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs NATCOPHARM |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.07 | ¥53.04 | +10% | vs NATCOPHARM |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,880 | ₹1,983 | +5% | vs NATCOPHARM |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs NATCOPHARM |
| Merck KGaA MRK | €149.60 | €108.83 | −27% | vs NATCOPHARM |
| Galderma Group GALD | CHF 191.40 | CHF 112.30 | −41% | vs NATCOPHARM |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs NATCOPHARM |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs NATCOPHARM |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs NATCOPHARM |
| Divi's Laboratories Limited DIVISLAB | ₹11,442 | ₹1,567 | −86% | vs NATCOPHARM |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Natco Pharma Limited (NATCOPHARM) overvalued or undervalued?
What is the fair value of NATCOPHARM?
What is the quality score of NATCOPHARM?
What is the price target for Natco Pharma Limited (NATCOPHARM)?
What is the Natco Pharma Limited stock forecast for 2026?
What is the revenue of Natco Pharma Limited (NATCOPHARM)?
Does Natco Pharma Limited pay a dividend?
How much is the dividend of Natco Pharma Limited (NATCOPHARM) and when is the ex-dividend date?
What growth is priced into Natco Pharma Limited (NATCOPHARM)?
What discount rate (WACC) does the fair value of NATCOPHARM use?
What is a reverse DCF?
How much growth has Natco Pharma Limited (NATCOPHARM) delivered so far?
How fast is the sector of Natco Pharma Limited (NATCOPHARM) growing?
What is the free cash flow yield of Natco Pharma Limited (NATCOPHARM)?
What is the intrinsic value of Natco Pharma Limited (NATCOPHARM)?
Is Natco Pharma Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of NATCOPHARM?
How much is Natco Pharma Limited worth?
What do the bullish and bearish scenarios say about NATCOPHARM?
What is the P/E ratio of NATCOPHARM?
How solid is the balance sheet of Natco Pharma Limited (NATCOPHARM)?
How far is NATCOPHARM from its 52-week high?
Which stocks are comparable to Natco Pharma Limited?
Is Natco Pharma Limited stock attractive at the current price?
How is the fair value of NATCOPHARM calculated?
Is it still worth investing in stocks now?
What is the share price of Natco Pharma Limited (NATCOPHARM)?
What should I pay attention to with Natco Pharma Limited right now?
Where does the earnings growth of Natco Pharma Limited (NATCOPHARM) come from?
Key figures of Natco Pharma Limited
How large is the market capitalisation of Natco Pharma Limited (NATCOPHARM)?
What is the P/S ratio of Natco Pharma Limited (NATCOPHARM)?
What are the earnings per share of Natco Pharma Limited (NATCOPHARM)?
What is the dividend yield of Natco Pharma Limited (NATCOPHARM)?
What is the net margin of Natco Pharma Limited (NATCOPHARM)?
What is the return on equity of Natco Pharma Limited (NATCOPHARM)?
What is the EBIT return on assets of Natco Pharma Limited (NATCOPHARM)?
What is the operating margin of Natco Pharma Limited (NATCOPHARM)?
How fast is revenue growing at Natco Pharma Limited (NATCOPHARM)?
How fast are earnings growing at Natco Pharma Limited (NATCOPHARM)?
How much net debt does Natco Pharma Limited (NATCOPHARM) carry?
Watch Natco Pharma Limited in the live analysis
One click puts Natco Pharma Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.